Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study (Q64693500)
Jump to navigation
Jump to search
clinical trial
Language | Label | Description | Also known as |
---|---|---|---|
English | Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study |
clinical trial |
Statements
CERTAIN 2 (English)
0 references
A Phase IIIB, Multi-center, Open Label Follow-up Study to Evaluate the Safety and Efficacy of Certolizumab Pegol Administered Concomitantly With DMARDs in Patients With Active Rheumatoid Arthritis Who Participated in C87076. (English)
0 references
January 2009
0 references
December 2012
0 references
131
0 references
18 year
0 references